NATALIE NICHOLSON: Open Payments
NPI 1780105924 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,119 in 59 payments from 18 companies in 2025. Trend: 2023 $309 · 2024 $1,765 · 2025 $2,119
Food & beverage: $2,119
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $779 |
| Olympus America Inc. | 9 | $298 |
| ABBVIE INC. | 9 | $214 |
| Boston Scientific Corporation | 2 | $170 |
| PFIZER INC. | 6 | $114 |
| BIOTISSUE HOLDINGS INC. | 1 | $80 |
| Ferring Pharmaceuticals Inc. | 2 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Teleflex LLC | 1 | $58 |
| Astellas Pharma US Inc | 2 | $51 |
Products named: RYBREVANT, ERLEADA, iTIND System, BOTOX, XTANDI, LithoVue, ADSTILADRIN, Nubeqa.
Industry payments across TX — which companies pay providers there.
